Live-attenuated H7N9 influenza vaccine is weak, yet strong
- PMID: 26673390
- DOI: 10.1016/S1473-3099(15)00425-9
Live-attenuated H7N9 influenza vaccine is weak, yet strong
Comment on
-
H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial.Lancet Infect Dis. 2016 Mar;16(3):303-10. doi: 10.1016/S1473-3099(15)00378-3. Epub 2015 Dec 8. Lancet Infect Dis. 2016. PMID: 26673391 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical